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Role of terminal complement pathway in the heterologous phase of
antiglomerular basement membrane nephritis. Terminal complement
components, including the membrane attack complex, have been dem-
onstrated in glomeruli of patients with immune complex and anti-GBM
nephritis. We recently demonstrated the functional significance of C6 in
the mediation of experimental membranous nephropathy in rabbits. In
the present study, the role of C6 was examined in the heterologous
phase of rabbit anti-GBM nephritis by studying normal and C6-deficient
(C6D) rabbits. In C6D rabbits, C6 hemolytic activity was less than
0.0 1% of control. All control rabbits became heavily proteinuric in the
first 24 hr following injection of a standard dose of sheep anti-rabbit
GBM antibody (mean, 42.0 26.3; range, 18.4 to 83.5 mg protein/mg
creatinine, N = 5). In contrast, C6D rabbits excreted a mean of only 5.1
5.5 mg/mg creatinine (range, 0.06 to 14.4, N = 6, P = 0.002). Protein
excretion in normal rabbits was less than 0.06 mg/mg creatinine. Both
control and C6D rabbits had similar deposits of sheep anti-rabbit GBM
IgG in glomeruli when measured by radiolabeling techniques (control
15.8 2.71, N = 5; C6D 18.7 1.99 g of sheep IgG/104 glomeruli, N
= 6, P > 0.05). Control rabbits had a greater rise in serum creatinine in
the first 24 hr (1.74 1.15 vs. 0.53 0.44 mg/dl, P < 0.05). Both groups
had similar deposits of sheep IgG and rabbit C3 by IF. By light
microscopy at 4 and 24 hr, both groups had qualitatively similar
proliferative changes and similar numbers of neutrophils infiltrating
glomeruli. C6 is critical in the mediation of proteinuria and decreased
renal function in the heterologous phase of anti-GBM nephritis in
rabbits thus demonstrating a requirement for this terminal complement
component for full expression of this form of glomerular injury.
Role de Ia vole terminale du complement dans Ia phase heterologue de
Ia néphrite anti-membrane basale glomerulaire. Les facteurs corn-
plémentaires terminaux dont le complexe d'attaque membranaire ont
été démontrés dans les glomerules de malades atteints de nephrite a
complexes immuns et anti-GBM. Nous avons récemment démontré la
signification fonctionnelle du C6 dans la mediation d'une néphropathie
extra-membraneuse expérimentale chez des lapins. Dans cette étude, le
role du C6 a etC examine a Ia phase heterologue d'une nephrite
anti-GBM de lapin par l'étude de lapins normaux et déficients en C6
(C6D). Chez les lapins C6D, l'activité hemolytique du C6 Ctait de moms
de 0,01% du contrôle. Tons les lapins contrOles devenaient trés
protCinuriques dans les 24 premieres heures apres injection d'une dose
standard d'anticorps de mouton anti-GBM de lapin (moyenne, 42,0
26,3; extremes 18,4 a 83,5 mg protCine/mg crCatinine, N 5, P =
0,002). A l'opposC, les lapins C6D excrCtaient one moyenne de seule-
ment 5,1 5,5 mg/mg crCatinine (extreme 10,06 a 14,4, N 6, P =
0,002). L'excrCtion protCique de lapins normaux Ctait de moms de 0,06
mg/mg créatinine. Les lapins contrôles et C6D avaient des depOts
semblables d'IgG de mouton anti-GBM de lapin dans leurs glomCrules,
mesurCs par des techniques de radio-marquage (contrOles 15,8 2,71,
N = 5; C6D 18,7 1,99 ig d'IgG de mouton/104 glomérules, N = 6, P
> 0,05). Les lapins contrOles avaient one ClCvation plus forte de leur
crCatinine sCrique lors des 24 premieres heures (1,74 1,15 contre 0,53
643
0,44 mg/dl, P < 0,05). Les deux groupes avaient des dCpôts d'IgG de
mouton et de C3 de lapin identiques en IF. En microscopie optique a 4
et 24 heures, les deux groupes avaient des modification prolifCratives
qualitativement identiques, et des nombres de neutrophiles infiltrant les
glomCrules semblables. Le C6 est critique dans Ia mediation de Ia
protCinurie et de Ia diminution de Ia fonction rénale au coors de la phase
hCtérologue de Ia néphrite anti-GBM de lapin, démontrant ainsi Ia
nCcessitC de ce facteur terminal du complement pour one expression
complete de cette forme d'atteinte glomerulaire.
The complement system is well established to be a major
mediator of immune glomerular injury induced by both anti-
GBM antibody and immune complex mechanisms [1—31. Until
recently, the mechanism of complement-mediated capillary
wall injury was believed to be an indirect one involving recruit-
ment of inflammatory effector cells either by generation of
chemotactic C5a fragments of complement activation or
through C3b receptor-mediated immune adherence mechanisms
with tissue injury produced by the effector cells rather than by
the complement itself.
In addition to its capacity to produce inflammatory tissue
injury, complement is also known to have cytolytic properties
that are found in a surface-bound complex of the terminal
complement component C5b-9, the membrane attack complex
(MAC) [4—6]. Recent immunofluorescent studies of renal tissue
samples from patients with systemic lupus erythematosus
(SLE) [7], idiopathic membranous nephropathy [8], and anti-
GBM nephropathy [81, and rats with chronic serum sickness
[9], have identified neoantigens of the MAC in glomerular
immune deposits. Poly C9, a polymer of C9 that forms part of
the MAC, has also been demonstrated in glomerular lesions of
patients with a variety of immune and non-immune renal
diseases [101. However, none of these observations differen-
tiate between a terminal complement mechanism as a cause of
tissue injury, as distinct from, activation of complement with
assembly of the MAC as a consequence of tissue damage.
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Recently, we demonstrated for the first time, a pathogenic
role for the sixth component of complement (C6) in mediating
experimental immune glomerular injury in a model of experi-
mental membranous nephropathy in the rabbit induced by
repeated immunization with cationized BSA [11]. Rabbits defi-
cient in C6, and thus unable to assemble the MAC [12], had a
marked decrease in proteinuria compared to control rabbits
with equivalent amounts of glomerular antibody deposits [11].
In the present studies, we have extended these observations
on the role of terminal complement components in mediating
immune glomerular injury to a second model of experimental
glomerulonephritis. The heterologous phase of nephrotoxic, or
anti-GBM, nephritis (NTN) in rabbits is a model in which
glomerular injury has been shown to be significantly reduced by
depletion of both complement and neutrophils [1, 13, 14].
Although previous studies of NTN in C6-deficient (C6D) rabbits
concluded that C6 was not involved in the pathogenesis of
proteinuria [151, rabbits were studied only during the later
autologous phase of the disease which is now known to be
complement-independent [16, 17]. We studied the heterologous
phase of NTN in control and C6D rabbits to determine if the
complement-mediated injury involved terminal complement
components. The amount of proteinuria induced in 24 hr
following anti-GBM antibody injection was compared in normal
and C6-deficient rabbits, and the amount of antibody deposited
in both groups was quantitated. Our observations demonstrate
a significant role for C6 in the development of proteinuria in this
model and added further support to a role for the MAC in
mediating glomerular immune inj ury.
Methods
Preparation of nephroloxic serum (NTS)
Isolated, intact glomeruli prepared from normal rabbit kid-
neys (Pel-Freeze, Rogers, Arkansas, USA) by differential siev-
ing techniques [18, 191 and emulsified in complete Freund's
adjuvant (Difco Corporation, Detroit, Michigan, USA) were
used to immunize a sheep according to previously published
schedules [201. The nephrotoxic serum was heat-inactivated at
56°C for 30 mm and absorbed extensively with rabbit red blood
cells and serum. The IgG fraction was isolated from a 50%
ammonium sulfate precipitate of absorbed NTS by ion-
exchange chromatography on DEAE-Sephacel (Pharmacia Fine
Chemicals, Inc., Piscataway, New Jersey, USA) using 0,0175 M
sodium phosphate buffer, pH 7.4. The yl (complement-fixing)
lgG fraction was eluted using the starting buffer and a linear salt
gradient to 0.2 M. All fractions containing yl IgG were pooled,
dialyzed, concentrated to 22 mg/mI, and stored at —70°C until
used. A dose response curve was obtained by administering
increasing doses of yl sheep lgG to groups of normal rabbits, A
dose of yl sheep IgG of 12 mg/kg was found to consistently
induce heavy proteinuria in the 24-hr period following intra-
venous injection.
The yl sheep lgG was radio-labeled with 125! using the
chloramine T method [21, 22]. Specific activity was 3.1 x l0
cpm/g protein of which 95% was precipitated with 10%
trichloroacetic acid (TCA).
As a paired-label control for non-specific binding of IgG in
glomeruli, normal rabbit lgG was isolated from a 50% am-
monium sulfate precipitate of normal rabbit serum and radio-
labeled with [21, 22]. Specific activity was 3.7 x 104 cpm/g
protein, and 95% was precipitated with 10% TCA.
Experimental protocol
To assess the effect of C6 deficiency on heterologous phase
proteinuria in NTN, New Zealand white rabbits (2.0 to 3.0 kg,
Pine Acre Rabbitry, Battleboro, Vermont, USA) and C6-
deficient rabbits (raised from a breeding colony obtained from
the National Institutes of Health, Bethesda, Maryland, USA)
were utilized. C6 levels were determined in normal and C6
deficient rabbits by hemolytic assay prior to study (see below).
All rabbits were injected with the same dose of 12 mg/kg of 125J
sheep anti-rabbit GBM yl IgG i.v.; 4 hr later they were placed
in metabolic cages and urine samples were collected for 24 hr
for measurement of protein and creatinine excretion. After
completion of the urine collection, rabbits were injected with 18
mg of 131j normal rabbit IgG i.v., and 1 hr later they were
sacrificed by lethal injection of Nembutal (Abbott Pharma-
ceuticals, North Chicago, Illinois, USA). Glomeruli were iso-
lated from fresh kidney cortex for measurement of glomerular
antibody deposition as outlined below.
Preliminary studies were also done to assess the role of
neutrophils in mediating heterologous phase proteinuria. In
these studies, absorbed sheep nephrotoxic serum was used
rather than the yl fraction. Two groups of rabbits were studied:
group 1, normal rabbits, and group 2, normal rabbits depleted of
neutrophils. Neutrophil depletion was produced by injection of
nitrogen mustard (Mustargen, Merck, Sharp & Dohme, West
Point, Pennsylvania, USA) 1.75 mg/kg i.v. followed in 36 hr by
a second dose of 1.0 mg/kg [17]. Total peripheral white blood
cell and differential counts were performed on the animals prior
to nitrogen mustard administration, and again prior to injection
of nephrotoxic serum.
Measurement of urine protein excretion, serum creatinine,
and serum complement activity
Urine protein was measured by a sulfosalicylic acid method
on 24-hr urine collections using a whole serum standard (Lab—
Trol, Dade Division, American Hospital Supply Corp., Miami,
Florida, USA). Results of 24-hr protein excretion were ex-
pressed as milligrams of protein per milligrams of creatinine to
correct for inaccuracies in the volume of timed urine collections
in rabbits [23]. Serum and urine creatinine were measured by
the Jaffe method (Worthington Diagnostics, Freehold, New
Jersey, USA). To determine normal values for 24-hr protein
excretion in NZW rabbits of this size, 24-hr protein excretion
was measured in ten male animals. The 95% confidence limits
were calculated from these results.
Specific C6 hemolytic activity was measured in normal and
C6D rabbits with EAC lgp 4hu and an excess of human C2, C3,
CS, and C7 and guinea pig C8 and C9 by a modification of the
method of Kabat and Mayer [24] exactly as described by the
suppliers of the reagents (Cordis Laboratories, Miami, Florida,
USA). The percent lysis was determined by comparison to an
equal volume of cells lysed in distilled water. The dilution
giving 50% lysis was calculated. The reciprocal of this value
was the number of CH 50 U/mI.
Peripheral blood leukocyte counts were determined on a
counter (model ZBI, Coulter Electronics, Inc., Hialeah, Flor-
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ida, USA). The percentage of neutrophils was calculated from
the number of neutrophils in 100 randomly counted leukocytes
on a peripheral smear stained with Wright's stain.
Measurements of glomerular antibody binding
The glomerular deposits of sheep anti-rabbit GBM yl IgG
were quantitated by methods similar to those described previ-
ously [22, 25]. At the time of sacrifice, blood samples were
obtained and levels of 1251 and '311-labeled IgG in the circula-
tion were measured. The kidneys were promptly removed and
glomeruli were isolated as previously described [22]. Glomeruli
from both kidneys in each animal were pooled and suspended in
PBS and a 3-ml aliquot was taken. The content of 1311 and 125J
IgG were determined in each aliquot, and the glomeruli in each
aliquot were then counted visually [II]. In all cases, the number
of glomeruli ranged from 21,000 to 45,000 in 3-ml aliquots. All
glomerular counts were corrected for background and spillover.
Specific sheep IgG deposits in the glomeruli of individual
animals was calculated as follows:
/ G 131j \
Specific glomerular 1251 = G 125J )B
l25J
where G 1251 and G 131J are cpm of 1251 and I31J in the aliquot of
glomeruli and B 125J and B 131J are cpm of 1251 and 131J in 1 ml of
whole blood [25].
Counts per minute were converted to micrograms of sheep
IgG using the specific activity. Results are expressed as micro-
grams of sheep IgG per 10,000 glomeruli,
Tissue processing and IF procedures
Tissue samples were obtained for light, immunofluorescence
(IF), and electron microscopy (EM) at sacrifice, 25 hr after NTS
administration. In some studies, tissue samples were also
obtained by open biopsy 4 hr after antibody injection. Tissue
samples for light microscopy were fixed in 10% neutral buffered
formalin, sectioned at 4 s, and stained with hematoxylin and
eosin and periodic acid-Schiff reagent.
Direct IF procedures were performed on renal tissue snap-
frozen in dry ice-isopentane, sectioned at 4 s in a cryostat, and
fixed in ether-alcohol as previously described [26]. All biopsy
specimens were stained with the fluorescein-conjugated IgG
fractions of monospecific antisera to sheep IgG, rabbit C3, and
rabbit IgG (Cappel Laboratories, Cochranesville, Pennsylva-
nia, USA).
Tissue samples for EM were fixed by immersion in
glutaraldehyde-paraformaldehyde mixture (2 g/dl paraform-
aldehyde, 2.5 g/dl glutaraldehyde in 0.1 M sodium cacodylate
buffer, pH 7.4), rinsed in cacodylate buffer, postfixed in I gldl of
aqueous osmium tetroxide for 2 hr, dehydrated in graded
ethanols, cleared in propylene oxide, and embedded in epoxy
resin. One micron-thick sections and ultra-thin sections (grey-
silver interference color) were cut on an LKB-Ultrotome (LKB
Instruments, Gaithersburg, Maryland, USA). Thick sections
were stained with toluidine blue and thin sections were stained
on the grid with uranyl acetate and lead citrate and examined in
an electron microscope (Phillips 201).
Statistical analysis
Urine protein excretion and glomerular antibody binding
results were evaluated by the Mann-Whitney U test for analysis
CONTROL C6D CONTROL C6D
Fig. 1. Proteinuria and glomerular antibody deposition 24 hr after
administration of nephrotoxic serum. On the left is the amount of sheep
anti-rabbit GBM IgG deposited in 10,000 glomeruli of control and C6D
rabbits. There was no difference in deposited sheep IgG between the
two groups (P < 0.05). On the right is the protein excretion in control
and C6D rabbits in the 24 hr after injection of the NTS. Results are
expressed as milligrams of protein per milligrams of creatinine. The
dashed line represents the upper 99% confidence limit in normal rabbits
(0.06 mg protein/mg creatinine). The difference between the groups is
significant (P = 0.002).
of non-parametric data [27]. Parametric data was evaluated by
unpaired t test [27]. All values are expressed as the mean 1 SD
unless otherwise indicated.
Results
Effect of C6 deficiency on urine protein excretion and serum
creatinine in NTN
Specific C6 hemolytic activity in 11 C6D rabbits tested was 5
0.6 CH5O U/ml. Six control rabbits had 60,667 5,206
CH5O U/ml of C6 hemolytic activity. No C6D rabbit studied had
a C6 level exceeding 8 CH5O U/mI.
The mean values for urine protein excretion in the first 24 hr
following administration of 12 mg/kg of nephrotoxic serum to
five normal control and 6 C6D rabbits are shown in Figure 1.
Control rabbits excreted a median of 43.3 mg protein/mg
creatinine (range, 18.4 to 83.5), while C6D rabbits had a median
of 4.0mg protein/mg creatinine (range, 0.06 to 14.4; P =0.002).
The urine protein excretion in the C6D group was significantly
greater than normal (P < 0.05), although one C6D animal had
protein excretion in the normal range following NTS adminis-
tration.
Control rabbits also had a significantly greater increase in
serum creatinine concentrations over baseline values when
measured 24 hr after NTS administration (mean increase, 1.74
1.15 mg%; range, 0.3 to 3.0; N = 5) compared to C6D rabbits
(mean increase, 0.53 .44 mg%; range, 0.2 to 1.4; N = 6, P <
0.05).
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Fig. 2. Immunofluorescent photomicrography at 24 hr in control (A and C) and C6D (B and D) rabbits. Similar deposits of sheep IgG (A and B)
are present in a linear pattern. Rabbit C3 (C and D) is also deposited in a linear pattern of similar intensity in both groups. (x450)
Quantitation of glotnerular deposition of nephroroxic IgG
Results of paired-label measurements of specific deposition
of nephrotoxic IgG in glomeruli of normal and C6D rabbits are
shown in Figure 1. Control animals had a mean of 15.80 2.71
of sheep IgG deposited per 10,000 glomeruli at 24 hr (range,
12.58 to 19.30) while C6D animals had a mean of 18.65 1.99
g per 10,000 glomeruli (range, 15.37 to 21.34). There was no
significant difference between the two groups (P > 0.05).
Effect of neutrophil depletion on proteinuria
Neutrophil depletion was induced in five normal rabbits by
injection of nitrogen mustard prior to administration of
nephrotoxic serum. In neutrophil-depleted rabbits the total
peripheral neutrophil counts before NTS administration were
less than 100/mm3 and total circulating leukocytes were less
than 1,000/mm3 compared to 2,100 to 5,040 neutrophils/mm3
and 5,200 to 9,022 leukocytes/mm3 prior to the administration of
nitrogen mustard. Although neutrophil depletion appeared to
reduce proteinuria in most rabbits (median 6.5 mg protein/mg
creatinine; range, 4.2 to 15.6; N = 5), the difference as
compared to controls (median 14,5 mg protein/mg creatinine;
range 0.2 to 37.9; N = 4) was not significant due to the wide
range and absence of proteinuria in one control rabbit.
Morphologic studies
No significant differences were apparent by light, IF, and EM
between control, C6D, and neutrophil-depleted rabbits except
for the absence of glomerular neutrophil infiltration in the
neutrophil-depleted animals and more extensive epithelial cell
foot process effacement by EM in control animals reflecting the
differences in urine protein excretion. IF studies at 24 hr
showed 3 — 4 + linear deposits of sheep IgG in glomeruli of
both control and C6D rabbits (Fig. 2A and B). IF studies at 4 hr
for sheep IgG were similar to 24 hr. Rabbit C3 deposits were
also linear but were only of trace intensity at 4 hr and I — 2 +
at 24 hr. No differences were detectable between the two
groups (Fig. 2C and D). No specific deposition of rabbit IgG
could be detected. Neutrophil depletion had no effect on
glomerular immune deposits as judged by IF.
By light microscopy, both control and C6D rabbits had mild
intrinsic glomerular cell proliferation, prominent inflammatory
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Fig. 3. Light micrographs showing representative glomeruli from con-
trol (A), C6-deficienr (B), and neutrophil-depleted (C) rabbits at 24 hr.
Note the increased cellularity in A and B. Arrows indicate several
polymorphonuclear leukocytes which are absent from glomeruli of
neutrophil-depleted rabbits (C). (H&E x430)
cell infiltrates, and early crescent formation in some glomeruli
at 24 hr. There was no apparent difference in morphology
between control and C6D animals (Fig. 3A and B). The glomer-
ular inflammatory cell infiltrate was markedly reduced in nitro-
gen mustard-treated animals (Fig. 3C). At 4 hr also, there was
no difference between control and C6D rabbits in terms of
proliferation and infiltration.
Electron microscopy in control and C6D rabbits revealed
areas of separation of endothelium from basement membrane in
both groups, no electron dense deposits, and more extensive
epithelial cell foot process effacement in control animals as
compared to C6D animals (Fig. 4A and B).
Discussion
The purpose of these studies was to test the hypothesis that
the terminal complement pathway (C5b-9) is an important
mediator of glomerular immune injury in the heterologous
phase of nephrotoxic nephritis (NTN) in the rabbit. We found
that rabbits deficient in C6 have a marked reduction in
heterologous phase proteinuria and a smaller increase in serum
creatinine compared to normocomplementemic controls that
had equivalent amounts of antibody deposited in their
glomeruli.
The mechanism by which C6 participates in causing glomeru-
lar injury in NTN has not been defined by these studies. Several
processes are known to mediate proteinuria in the heterologous
phase of NTN. These include a direct effect of anti-GBM
antibody deposition alone on glomerular permeability [13], an
early lymphocyte-mediated alteration in glomerular charge bar-
rier [28], and later phases of injury mediated first by neutrophils
and later by mononuclear cells [14, 29]. Deposition of anti-GBM
antibody also causes a marked decrease in glomerular filtration
rate (GFR) due to a reduction in renal plasma flow and Kf
accompanied by a rise in the filtration fraction [30—321. These
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Fig. 4. High-power electron micrographs of the glo,nerular capillary wall of a control (A) and Co-deficient (B) rabbit at 24 hr. Effacement of
epithelial cell foot processes is seen in both groups and is especially prominent in A which also shows distortion of filtration slit diaphragms. Focal
detachment of endothelial cells was also observed in both groups and is illustrated in B. Some capillary loops in both groups contained
polymorphonuclear leukocytes (PMN) as depicted in A. Abbreviations are: US, urinary space; EP, glomerular epithelial cell; End, endothelium;
CL, capillary lumen. (x3900)
hemodynamic changes are similar to ones induced by angioten- increase in the filtration fraction, the apparently less marked
sin II infusion and may further contribute to increased protein reduction in GFR in C6D rabbits as judged by measurements of
filtration on a purely hemodynamic basis [331. serum creatinine may have contributed to some reduction in
Among these events, complement is known to contribute that quantity of protein filtration which occurs on a hemody-
only to the reduction in GFR and to the neutrophil-dependent namic basis. However, the magnitude of the differences in GFR
portion of proteinuria. To the extent that some proteinuria in between C6D and control animals was small, and any tendency
NTN may be attributable to hemodynamic changes and to an for increased albumin filtration to occur as a consequence of a
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higher filtration fraction in controls would probably be offset by
the greater reduction in total kidney GFR. It therefore seems
unlikely that hemodynamic factors played a major role in
accounting for the differences in protein excretion observed
between control and C6 deficient groups.
With regard to the possible role of neutrophils in this study,
participation of a complement-neutrophil-dependent mecha-
nism of glomertilar injury in rabbit NTN has been well estab-
lished by the work of Cochrane, Henson, and others who have
shown a correlation between glomerular neutrophil infiltration
and proteinuria [14], a marked reduction in the neutrophil
infiltration and proteinuria following depletion of C3-C9 with
cobra venom factor [14, 34, 35], and restoration of proteinuria
in normocomplementemic, neutrophil-depleted rabbits by
neutrophil-replacement [361. Based largely on these studies, the
known in vitro chemotactic properties of complement-
activation products such as C5a [37], and the capacity of
neutrophil-derived enzymes to degrade normal GBM in vitro
[38, 39], it has been presumed that the pathogenic role of
complement in glomerular disease largely reflected its capacity
to recruit inflammatory effector cells [1]. That the abrogation of
proteinuria in C6-deficient rabbits in these studies was not due
to impaired neutrophil function or chemotaxis production is
suggested by the following observation. Chemotactic factor
generation and leukocyte function have been shown to be
normal in C6-deficient animals [37]. In addition, glomerular
neutrophil infiltrates and C3 deposits in control and C6-deficient
animals in our studies were qualitatively indistinguishable by
light and fluorescent microscopy at 4 and 24 hr following
antibody injection, despite the marked reduction in proteinuria
in the C6 deficient group. These data argue strongly for a direct
effect of the terminal complement mechanism on the glomerular
filtration barrier independent of inflammatory effector cells. Our
findings are not inconsistent with previous studies in which
neutrophil depletion has proven only partially successful in
preventing proteinuria in rabbits given large doses of
nephrotoxic serum [14, 34] suggesting the presence of an
additional neutrophil-independent effect. Moreover, our find-
ings do not argue against a role for a complement-neutrophil-
dependent mechanism in this model. C6 deficient rabbits had
levels of protein excretion that exceeded normal controls by a
factor of over 60, presumably reflecting a neutrophil-mediated
component of immune injury. This suggestion is consistent with
our preliminary studies of neutrophil depletion in this model
which showed a reduction in proteinuria in neutrophil-depleted
rabbits, although the numbers obtained do not reach statistical
significance. However, our findings suggest that the relative
importance of the direct complement effect in the total magni-
tude of anti-GBM antibody-induced glomerular injury may be at
least as great as any effect attributable to a complement-neutro-
phil-mediated process.
The conclusion from this study that a terminal complement
mechanism plays a direct role in mediating glomerular injury in
NTN extends to a new form of glomerular disease our conclu-
sions drew from previous studies in which this effect was
observed first in the initial stages of chronic serum sickness in
the rabbit induced by daily injections of cationized BSA [11].
We believe the mechanism is also analogous to the
complement-dependent, cell-independent type of antibody-
mediated glomerular injury we first described in the passive
Heymann model of experimental membranous nephropathy in
rats [21, and later in experimental membranous nephropathy in
rats induced with a planted glomerular antigen [31, although the
latter studies did not specifically implicate a terminal comple-
ment component. An apparently similar form of tissue injury
has been reported in other organ systems as well. Thus,
hyperacute rejection of cardiac allografts in rats depends on
complement but is independent of neutrophils [40, 41], and C6
deficient rabbits are known to have a delayed hyperacute
rejection of heart xenografts [421.
The nature of the terminal complement mechanism described
in our present and previous studies has not yet been clearly
defined. C5 has some serine protease activity, but it is difficult
to relate this to glomerular disease [12]. C6-deficient rabbit
blood has been observed to have delayed clotting in vitro in
response to activation of the terminal complement pathway [43,
44]. However, it is unlikely that any putative clotting defect
protected C6-deficient rabbits from glomerular injury, since we
found little evidence of fibrin deposition in this model; studies
by others have shown no protective effect of either generalized
anticoagulation [45] or defibrination [46] on proteinuria in NTN
in the rabbit. The possibility that terminal complement compo-
nents may stimulate local production of intraglomerular hu-
moral mediators with pathogenic potential such as products of
arachidonic acid metabolism or reactive oxygen species cannot
be excluded by existing data [47, 48]. However, there is now
growing evidence that the terminal complement mechanism
probably involves assembly of a cytolytic membrane attack
complex (MAC) with consequent structural damage to some
important functional component(s) of the filtration barrier.
Thus, neoantigens of the MAC have been identified recently at
sites of immune deposits in a variety of human renal diseases [7,
8, 10] and are associated with terminal complement component
deposition in several models of experimental glomerulonephri-
tis in the rat [9, 49] where they appear to correlate with a role
for complement in mediating proteinuria [49]. Although both
human and experimental studies suggest that a variety of
damaged renal tissues may spontaneously activate complement
to produce MAC assembly, the results of this study and our
previous observations in chronic serum sickness in the rabbit
strongly suggest that the terminal complement pathway, and by
inference MAC formation, is an important primary pathoge-
netic event in immune renal disease. The cytolytic action of
complement is attributed generally to the insertion of MACs
into the phospholipid bilayer of cell membranes to form an
annular structure with resulting loss of cell membrane integrity
due to formation of transmembrane channels [5] or to loss
and/or rearrangement of membrane phospholipids [50, 51].
Such damage could be induced in either glomerular endothelial
or epithelial cells by antibodies in a crude preparation of
heterologous nephrotoxic serum such as that used in this study
and thereby result in either a direct disruption of the size-
selective filtration barrier or exposure of basement membrane
to the circulation with subsequent activation of other sources of
vasoactive mediators such as platelets or inflammatory cells.
Alternatively, MAC formation and insertion may occur within
the GBM itself as recently shown with alveolar basement
membrane [52]. Such a process could disrupt directly the lattice
structure of GBM required to maintain impermeability to serum
proteins as apparently occurs with binding of some antibodies
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to structural components of the glomerular capillary wall [13,
531. Obviously, further studies are required to better under-
stand this process.
The documentation of a role for terminal complement com-
ponents in mediating glomerular injury in the hctcrologous
phase of NTN in the rabbit adds an important new mechanism
of tissue damage to the several already defined in this classic
model of immune renal disease [13]. The recognition of this new
direct complement mechanism in a lesion previously thought to
be largely complement-neutrophil-dependent suggests the need
to re-evaluate the role of complement in the pathogenesis of a
variety of renal and non-renal forms of tissue injury.
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